Marwan Dib Selected Research

lexipafant

6/2002

Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marwan Dib Research Topics

Disease

2	Lung Injury 10/2009 - 03/2005
2	Pancreatitis 07/2005 - 03/2005
2	Ischemia 07/2002 - 06/2002
1	Edema (Dropsy) 10/2009
1	Hemorrhage 10/2009
1	Inflammation (Inflammations) 10/2009
1	Pulmonary Edema 10/2009
1	Sepsis (Septicemia) 03/2005
1	Reperfusion Injury 07/2002

Drug/Important Bio-Agent (IBA)

2	Oxygen (Dioxygen)IBA 10/2009 - 06/2002
1	Peptides (Polypeptides)IBA 10/2009
1	Adenosine Triphosphatases (ATPase)IBA 10/2009
1	LigandsIBA 10/2009
1	MetallothioneinIBA 10/2009
1	Proteins (Proteins, Gene)FDA Link 10/2009
1	Substance PIBA 10/2009
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 10/2009
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2009
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2005
1	Mast Cell StabilizersIBA 07/2005
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 07/2005
1	Taurodeoxycholic AcidIBA 07/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2005
1	Monoclonal AntibodiesIBA 07/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2002
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2002
1	Cell Adhesion MoleculesIBA 06/2002
1	Free RadicalsIBA 06/2002
1	Platelet Activating FactorIBA 06/2002
1	lexipafantIBA 06/2002

Therapy/Procedure

1	Punctures 03/2005
1	Ligation 03/2005